«A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease». One Health & Risk Management 4, no. 4 (september 29, 2023): 19–26. åpnet juli 11, 2026. https://ojs.maxaccs.ie/index.php/journal-ohrm-bba-md/article/view/374.